Blood Advances发表Cellworks前瞻性基因组生物模拟研究，预测癌症治疗反应的准确率达到90%
September 19, 2019 12:13 ET
|
Cellworks Group, Inc.
旧金山, Sept. 20, 2019 (GLOBE NEWSWIRE) -- 精密医学领先机构及肿瘤治疗应答指数检测（TRI）技术的全球先锋企业 Cellworks 集团今天宣布：美国血液学会（ASH）期刊《Blood Advances》刊登了 iCare...
Blood Advances Publishes Cellworks Prospective Genomic Biosimulation Study that Predicts Cancer Therapy Response with 90% Accuracy
September 19, 2019 12:13 ET
|
Cellworks Group, Inc.
SAN FRANCISCO, Sept. 19, 2019 (GLOBE NEWSWIRE) -- Cellworks Group, Inc., a leader in Precision Medicine and a global pioneer of Therapy Response Index (TRI) technology, today announced that Blood...